Intralesional triamcinolone alone or in combination with botulinium toxin A is ineffective for the treatment of formed keloid scar: A double blind controlled pilot study.

Rasaii S, Sohrabian N, Gianfaldoni S, Hadibarhaghtalab M, Pazyar N, Bakhshaeekia A, Lotti T, Ramirez-Pacheco LA, Lange CS, Matta J, Seifi V, Ramirez-Fort MK, Feily A. Intralesional triamcinolone alone or in combination with botulinium toxin A is ineffective for the treatment of formed keloid scar: A double blind controlled pilot study. Dermatol Ther. 2019 03; 32(2):e12781.

View in: PubMed

subject areas

Double-Blind Method
Drug Therapy, Combination
Female
Glucocorticoids
Humans
Injections, Intralesional
Keloid
Male
Neuromuscular Agents
Pain
Pilot Projects
Pruritus
Treatment Outcome
Triamcinolone Acetonide
Young Adult

authors with profiles

Jaime Matta

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support